Sarepta Therapeutics Balance Sheet - Annual (NASDAQ:SRPT)

Add to My Stocks
$29.68 $0.51 (1.69%) SRPT stock closing price Mar 23, 2017 (Closing)

The Sarepta Therapeutics balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Sarepta Therapeutics stock analysis. Quarterly results are typically accompanied with the company releasing financial statements. Sarepta Therapeutics had a long term debt of $14.96M at the end of 2015. Sarepta Therapeutics operating cash flow was $-149.46M while Sarepta Therapeutics revenue stood at $1.25M. View latest and last 10 year balance sheet data to check Sarepta Therapeutics financial performance..

show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2015 2014 2013 2012 2011 2010 2009 2008 2007
Marketable Securities122.88M136.79M7.25M---0.17M0.28M0.27M
Raw Materials---------
Work In Progress---------
Finished Goods---------
Notes Receivable---------
Other Current Assets17.38M35.03M3.06M1.53M1.64M1.02M0.77M0.59M0.76M
Sarepta Therapeutics Total Current Assets
Property Plant & Equipment61.93M58.39M32.37M20.1M20.03M17.03M16.49M18.1M18.64M
Accumulated Depreciation24.59M19.89M17.32M16.7M15.76M14.96M14.02M12.91M11.81M
Sarepta Therapeutics Net Property Plant & Equipment
Investment & Advances0.78M0.78M0.64M------
Other Non-Current Assets-----1.96M2.37M--
Deferred Charges--------3.06M
Deposits & Other Assets4.47M2.06M0.02M2.77M0.15M0.12M0.12M0.03M0.03M
Sarepta Therapeutics Total Assets
Notes Payable2.49M2.49M-------
Accounts Payable20.23M12.4M17.63M7.53M9.39M1.31M1.38M2.01M3.02M
Current Portion Long-Term Debt5.93M0.09M0.09M0.08M0.08M0.08M0.07M0.07M0.07M
Current Portion Capital Leases---------
Accrued Expenses29.05M17.36M5.04M2.74M2.24M2.01M0.92M1.3M1.17M
Income Taxes Payable---------
Other Current Liabilities4.57M4.5M13.19M68.52M8.87M42.45M31.12M3.89M5.48M
Sarepta Therapeutics Total Current Liabilities
Deferred Taxes/Income6.17M6.77M6.83M------
Convertible Debt---------
Long-Term Debt14.96M3.73M1.57M1.66M1.75M1.84M1.92M2M2.07M
Non-Current Capital Leases---------
Other Long-Term Liabilities---0.76M0.99M1.09M0.96M0.51M0.43M
Sarepta Therapeutics Total Liabilities
Minority Interest---------
Preferred Stock---------
Common Stock Net0.01M---0.01M0.01M0.01M0.01M0.01M
Capital Surplus1.09B926.76M790.42M554.92M340.96M304.81M299.08M266.03M252.73M
Retained Earnings-899.05M-679.02M-543.23M-431.25M-309.96M-307.64M-275.46M-250.31M-226.35M
Treasury Stock---------
Other Liabilities-0.11M-0.09M-------
Sarepta Therapeutics Shareholders Equity
Sarepta Therapeutics Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Balance sheet for another ticker

The latest Sarepta Therapeutics stock price, and Sarepta Therapeutics historical stock prices show the stock price movement over time, and the Sarepta Therapeutics PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:
  • Assets: An asset is a resource that a corporation like Sarepta Therapeutics owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for SRPT stock as of year is $273.78M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: The total liabilities of Sarepta Therapeutics for 2015 total to $83.43M. Liabilities for a company like Sarepta Therapeutics include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Sarepta Therapeutics Balance Sheet - Key Ratios

Current ratio
Debt to Equity ratio

Annual Balance Sheets For Sarepta Therapeutics Inc Peers

Aviragen Therapeutics balance sheet, BioCryst Pharma balance sheet, DBV Tech balance sheet, Gilead Sciences balance sheet, Halozyme Therapeutics balance sheet